Dr. Praveen Dougal
Executive Chairman, President and CEO
Replay available
Ocular Therapeutix, Inc. (OCUL) Q4 2024 Earnings Call
Ocular Therapeutix, Inc. (NASDAQ: OCUL) Q4 2024 earnings conference call, held 2025-03-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Tazeen Ahmad
Bank of America Analyst
Piper Sandler Analyst
Analyst (representing Beer and Amin with Piper Sandler)
Colleen Cousy
Baird Analyst
Kelly Shee
Jefferies Analyst
Sean McCutcheon
Raymond James Analyst
John Wolven
Citizens J&P Analyst
Yi Chen
H.E. Wainwright Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ocular Therapeutix, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.455 Good morning, and welcome to the Ocular Therapeutics Fourth Quarter 2024 Earnings Conference 00:00:04.455 -- 00:00:08.840 Call. At this time, all participants are in a listen-only mode. 00:00:08.840 -- 00:00:12.183 After the prepared remarks, we'll conduct a question-and-answer session. 00:00:12.183 -- 00:00:15.386 To ask a question, please press star 1. 00:00:15.386 -- 00:00:18.929 As a reminder, this conference call is being recorded and will be available for replay 00:00:18.929 -- 00:00:23.334 on the Investor Relations section of the Ocular Therapeutics website. 00:00:23.334 -- 00:00:27.297 I would now like to turn the call over to Ocular's Vice President of Investor Relations, 00:00:27.297 -- 00:00:31.560 Bill Slattery, Jr. Please go ahead, Mr. Slattery. 00:00:31.638 -- 00:00:35.524 Good morning, everyone, and thank you for joining us today. 00:00:35.524 -- 00:00:41.694 Earlier this morning, we issued a press release and filed our annual report on Form 10-K, 00:00:41.694 -- 00:00:46.100 outlining our financial results and business updates for the fourth quarter and full 00:00:46.100 -- 00:00:48.003 year of 2024, 00:00:48.003 -- 00:00:53.969 along with several updates to our registrational program for Xpaxly and WET-AMD. 00:00:54.233 -- 00:00:58.019 Ocular's Executive Chairman, President, and CEO, Dr. 00:00:58.019 -- 00:01:02.942 Praveen Dougal, We'll summarize recent business highlights before we move to our question 00:01:02.942 -- 00:01:05.442 and answer session. 00:01:05.545 -- 00:01:11.012 Joining Dr. Dougal for the Q&A portion of the call will be Donald Notman, Chief Financial 00:01:11.012 -- 00:01:16.498 Officer and Chief Operating Officer, Sanjay Nayak, Chief Strategy Officer, 00:01:16.498 -- 00:01:20.123 and Steve Myers...